Nuchal Translucency screening for Downs Syndrome

The procurement process for Nuchal Translucency screening for Down's Syndrome has been awarded by the Mersey and West Lancashire Teaching Hospitals NHS Trust, based in Prescot, UK. The contract was finalised on 5th June 2025, and it utilises a direct award procurement method due to an urgent business continuity requirement. The buyer, a central government public authority, opted for this process to ensure continuity in health and social work services.

This contract covers multiple regions across the UK, with delivery stretching from mid-June 2025 to the end of March 2027. The total value of the service is calculated based on a per-test basis, at a rate of £22.20. This procurement presents opportunities for businesses in the health sector, specifically those capable of providing medical testing services.

Suitable candidates for such tenders would likely include small and medium-sized enterprises (SMEs) and voluntary community sector enterprises (VCSEs) that can fulfil testing requirements on-site. While this particular award has been granted to Bolton NHS Foundation Trust, other similar opportunities may exist for healthcare providers aiming to expand their service portfolios or geographical outreach. Engaging in such contracts could lead to increased revenue streams and sector credibility for successful bidders.